Frontiers in Cell and Developmental Biology (Mar 2021)

LncRNA MTX2-6 Suppresses Cell Proliferation by Acting as ceRNA of miR-574-5p to Accumulate SMAD4 in Esophageal Squamous Cell Carcinoma

  • Jie Li,
  • Xu Han,
  • Xu Han,
  • Yan Gu,
  • Yan Gu,
  • Jixiang Wu,
  • Jixiang Wu,
  • Jianxiang Song,
  • Jianxiang Song,
  • Zhan Shi,
  • Zhan Shi,
  • Huiwen Chang,
  • Huiwen Chang,
  • Ming Liu,
  • Ming Liu,
  • Yajun Zhang,
  • Yajun Zhang

DOI
https://doi.org/10.3389/fcell.2021.654746
Journal volume & issue
Vol. 9

Abstract

Read online

Esophageal squamous cell carcinoma (ESCC) has been one of the key causes of cancer deaths worldwide. It has been found that long non-coding RNA (lncRNA) is related to the generation and progression of various cancers (including ESCC). However, there are still many lncRNAs related to ESCC whose functions and molecular mechanisms have not been clearly elucidated. In this study, we first reported that lncRNA MTX2-6 was significantly downregulated in ESCC tissues and cell lines. The decreased expression of MTX2-6 is closely related to larger tumor and worse prognosis of ESCC patients. Through a series of functional experiments, we detected that overexpressed MTX2-6 inhibited cell proliferation and promoted cell apoptosis of ESCC in vitro and in vivo. Further studies showed that MTX2-6 exerts as a competing endogenous RNA (ceRNA) by binding miR-574-5p and elevates the expression of SMAD4 in ESCC. In summary, our results clarify the tumor suppressor roles of MTX2-6/miR-574-5p/SMAD4 axis in the progression of ESCC and provide emerging therapeutic targets for ESCC patients.

Keywords